• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1999 - 2010年美国非结核分枝杆菌病死亡率:一项基于人群的比较研究

Nontuberculous mycobacterial disease mortality in the United States, 1999-2010: a population-based comparative study.

作者信息

Mirsaeidi Mehdi, Machado Roberto F, Garcia Joe G N, Schraufnagel Dean E

机构信息

Division of Pulmonary and Critical Care, University of Illinois at Chicago, Chicago, Illinois, United States of America.

Department of Medicine, University of Arizona, Tucson, Arizona, United States of America.

出版信息

PLoS One. 2014 Mar 14;9(3):e91879. doi: 10.1371/journal.pone.0091879. eCollection 2014.

DOI:10.1371/journal.pone.0091879
PMID:24632814
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3954860/
Abstract

BACKGROUND

Environmental nontuberculous mycobacteria (NTM) are ubiquitous organisms with which humans commonly interact. The epidemiologic characteristics of NTM diseases including mortality rate and its associated factors remain largely unknown. In this study, we explored the geographical area of exposure and mortality and comorbid conditions of affected persons to determine environment, host, and host-pathogen interactive factors.

METHODS

We analyzed mortality related to nontuberculous mycobacterial infections from 1999 through 2010 by examining multiple-cause-of-death data from the National Center for Health Statistics. Among those who died with these diseases, we analyzed age-adjusted mortality rates, trends, associations with demographic variables, and comorbid conditions and correlated this information with similar data for tuberculosis-related mortality during the same time.

MEASUREMENTS AND MEAN RESULTS

From 1999 through 2010, nontuberculous mycobacterial disease was reported as an immediate cause of death in 2,990 people in the United States with a combined overall mean age-adjusted mortality rate of 0.1 per 100,000 person-years. A significant increase in the number of NTM related deaths was seen from 1999 through 2010 (R(2) = 0.72, p<0.0001), but it was not significant after adjustment for age. Persons aged 55 years and older, women, those living in Hawaii and Louisiana, and those of non-Hispanic, white ethnicity had higher mortality rates. Compared to tuberculosis-related mortality, chronic obstructive pulmonary disease, bronchiectasis, HIV, interstitial lung diseases, and tobacco use were significantly more common in persons with nontuberculous mycobacteria-related deaths.

CONCLUSIONS

Nontuberculous mycobacteria-related death numbers are rising and are unevenly distributed. The strong association of nontuberculous mycobacterial disease with age suggests that its prevalence will increase as the United States population ages.

摘要

背景

环境非结核分枝杆菌(NTM)是人类普遍接触的广泛存在的生物体。NTM疾病的流行病学特征,包括死亡率及其相关因素,在很大程度上仍不清楚。在本研究中,我们探讨了受影响人群的暴露地理区域、死亡率和合并症,以确定环境、宿主以及宿主与病原体的相互作用因素。

方法

我们通过检查国家卫生统计中心的多死因数据,分析了1999年至2010年与非结核分枝杆菌感染相关的死亡率。在死于这些疾病的人群中,我们分析了年龄调整死亡率、趋势、与人口统计学变量的关联以及合并症,并将这些信息与同一时期结核病相关死亡率的类似数据进行了关联。

测量结果与均值

1999年至2010年期间,在美国有2990人报告非结核分枝杆菌病为直接死因,综合总体年龄调整死亡率为每10万人年0.1例。1999年至2010年期间,NTM相关死亡人数显著增加(R² = 0.72,p<0.0001),但在调整年龄后不显著。55岁及以上的人群、女性、居住在夏威夷和路易斯安那州的人群以及非西班牙裔白人的死亡率较高。与结核病相关死亡率相比,慢性阻塞性肺疾病、支气管扩张、HIV、间质性肺疾病和吸烟在非结核分枝杆菌相关死亡人群中明显更为常见。

结论

非结核分枝杆菌相关死亡人数正在上升且分布不均。非结核分枝杆菌病与年龄的密切关联表明,随着美国人口老龄化,其患病率将会增加。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e77f/3954860/838b129b7545/pone.0091879.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e77f/3954860/270d1c0d9e65/pone.0091879.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e77f/3954860/69c3a564191f/pone.0091879.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e77f/3954860/d0dabccb3a68/pone.0091879.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e77f/3954860/20a0f25e4d5b/pone.0091879.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e77f/3954860/838b129b7545/pone.0091879.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e77f/3954860/270d1c0d9e65/pone.0091879.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e77f/3954860/69c3a564191f/pone.0091879.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e77f/3954860/d0dabccb3a68/pone.0091879.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e77f/3954860/20a0f25e4d5b/pone.0091879.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e77f/3954860/838b129b7545/pone.0091879.g005.jpg

相似文献

1
Nontuberculous mycobacterial disease mortality in the United States, 1999-2010: a population-based comparative study.1999 - 2010年美国非结核分枝杆菌病死亡率:一项基于人群的比较研究
PLoS One. 2014 Mar 14;9(3):e91879. doi: 10.1371/journal.pone.0091879. eCollection 2014.
2
Deaths Related to Nontuberculous Mycobacterial Infections in the United States, 1999-2014.1999-2014 年美国与非结核分枝杆菌感染相关的死亡病例。
Ann Am Thorac Soc. 2016 Nov;13(11):1951-1955. doi: 10.1513/AnnalsATS.201606-474BC.
3
Population-based Incidence of Pulmonary Nontuberculous Mycobacterial Disease in Oregon 2007 to 2012.2007年至2012年俄勒冈州非结核分枝杆菌肺病的人群发病率
Ann Am Thorac Soc. 2015 May;12(5):642-7. doi: 10.1513/AnnalsATS.201412-559OC.
4
Nontuberculous mycobacterial pulmonary disease (NTM PD) incidence trends in the United States, 2010-2019.美国非结核分枝杆菌性肺病(NTM PD)发病率趋势,2010-2019 年。
BMC Infect Dis. 2024 Oct 2;24(1):1094. doi: 10.1186/s12879-024-09965-y.
5
Epidemiology of Adults and Children Treated for Nontuberculous Mycobacterial Pulmonary Disease in Japan.日本非结核分枝杆菌肺病患者的成人和儿童治疗的流行病学。
Ann Am Thorac Soc. 2019 Mar;16(3):341-347. doi: 10.1513/AnnalsATS.201806-366OC.
6
Prevalence, incidence, and mortality of nontuberculous mycobacterial infection in Korea: a nationwide population-based study.韩国非结核分枝杆菌感染的患病率、发病率和死亡率:一项全国性基于人群的研究。
BMC Pulm Med. 2019 Aug 1;19(1):140. doi: 10.1186/s12890-019-0901-z.
7
Effect of comorbidities on mortality in patients with nontuberculous mycobacterial infection in Korea: National Health Insurance Service-National Sample Cohort data.韩国非结核分枝杆菌感染患者合并症对死亡率的影响:国家健康保险服务-国家样本队列数据。
Sci Rep. 2024 Oct 1;14(1):22815. doi: 10.1038/s41598-024-73768-z.
8
Epidemiology of nontuberculous mycobacteria isolations among central North Carolina residents, 2006-2010.北卡罗来纳州中部居民中分离出的非结核分枝杆菌的流行病学研究,2006-2010 年。
J Infect. 2016 Jun;72(6):678-686. doi: 10.1016/j.jinf.2016.03.008. Epub 2016 Mar 18.
9
Increasing Prevalence Rate of Nontuberculous Mycobacteria Infections in Five States, 2008-2013.2008 - 2013年五个州非结核分枝杆菌感染患病率上升
Ann Am Thorac Soc. 2016 Dec;13(12):2143-2150. doi: 10.1513/AnnalsATS.201605-353OC.
10
Prevalence of Nontuberculous Mycobacterial Pulmonary Disease, Germany, 2009-2014.2009 - 2014年德国非结核分枝杆菌肺病的患病率
Emerg Infect Dis. 2016 Jun;22(6):1102-5. doi: 10.3201/eid2206.151642.

引用本文的文献

1
Immunity Against Induced by DAR-901 and BCG.由DAR-901和卡介苗诱导产生的免疫。
Vaccines (Basel). 2025 Jun 7;13(6):619. doi: 10.3390/vaccines13060619.
2
The role and clinical significance of myeloperoxidase (MPO) and TNF-α in prognostic evaluation of T-COPD.髓过氧化物酶(MPO)和肿瘤坏死因子-α(TNF-α)在T型慢性阻塞性肺疾病(T-COPD)预后评估中的作用及临床意义
BMC Pulm Med. 2025 Apr 23;25(1):192. doi: 10.1186/s12890-025-03655-4.
3
Multicenter, retrospective cohort study of antimycobacterial treatment-related harms among patients with non-tuberculosis infections in the United States.

本文引用的文献

1
Non-tuberculous mycobacterial disease is common in patients with non-cystic fibrosis bronchiectasis.非结核分枝杆菌病在非囊性纤维化支气管扩张症患者中很常见。
Int J Infect Dis. 2013 Nov;17(11):e1000-4. doi: 10.1016/j.ijid.2013.03.018. Epub 2013 May 16.
2
Underlying host risk factors for nontuberculous mycobacterial lung disease.非结核分枝杆菌肺病的潜在宿主危险因素。
Semin Respir Crit Care Med. 2013 Feb;34(1):110-23. doi: 10.1055/s-0033-1333573. Epub 2013 Mar 4.
3
Prevalence of nontuberculous mycobacteria in COPD patients with exacerbations.
美国非结核感染患者抗分枝杆菌治疗相关危害的多中心回顾性队列研究。
Antimicrob Agents Chemother. 2025 Apr 2;69(4):e0159624. doi: 10.1128/aac.01596-24. Epub 2025 Mar 4.
4
Assays for Assessing Immunity and Evaluating the Effects of Therapeutics.评估免疫力及评估治疗效果的检测方法
Pathogens. 2024 Oct 15;13(10):903. doi: 10.3390/pathogens13100903.
5
Extrapulmonary Mycobacterium abscessus Infections, France, 2012-2020.法国 2012-2020 年肺外脓肿分枝杆菌感染。
Emerg Infect Dis. 2024 Nov;30(11):2294-302. doi: 10.3201/eid3011.240459.
6
Effect of comorbidities on mortality in patients with nontuberculous mycobacterial infection in Korea: National Health Insurance Service-National Sample Cohort data.韩国非结核分枝杆菌感染患者合并症对死亡率的影响:国家健康保险服务-国家样本队列数据。
Sci Rep. 2024 Oct 1;14(1):22815. doi: 10.1038/s41598-024-73768-z.
7
Intrapulmonary pharmacokinetics of SPR719 following oral administration of SPR720 to healthy volunteers.健康志愿者口服 SPR720 后 SPK719 的肺部药代动力学。
Antimicrob Agents Chemother. 2024 Nov 6;68(11):e0110324. doi: 10.1128/aac.01103-24. Epub 2024 Oct 1.
8
Mortality Rate and Cause of Death in Adults with Extrapulmonary Nontuberculous Mycobacteria Infection, Denmark.丹麦成人肺外非结核分枝杆菌感染的死亡率和死因。
Emerg Infect Dis. 2024 Sep;30(9):1790-1798. doi: 10.3201/eid3009.240475.
9
Is there a role for lung or bronchial biopsies for the diagnosis of mycobacterial pulmonary disease in patients with bronchiectasis?对于支气管扩张症患者,肺活检或支气管活检在诊断分枝杆菌性肺病中是否有作用?
J Clin Tuberc Other Mycobact Dis. 2024 Apr 25;36:100447. doi: 10.1016/j.jctube.2024.100447. eCollection 2024 Aug.
10
Trends in Non-Tuberculous Mycobacterial Lung Disease and Treatment Outcomes in a Low-Tuberculosis Prevalence Setting: A Retrospective Analysis.低结核病流行地区非结核分枝杆菌肺病的趋势及治疗结果:一项回顾性分析
Pathogens. 2024 Apr 22;13(4):344. doi: 10.3390/pathogens13040344.
慢性阻塞性肺疾病(COPD)急性加重期患者非结核分枝杆菌的患病率
J Infect. 2013 Jun;66(6):542-5. doi: 10.1016/j.jinf.2012.12.011. Epub 2013 Jan 5.
4
Changes in B cell immunophenotype in common variable immunodeficiency: cause or effect - is bronchiectasis indicative of undiagnosed immunodeficiency?常见变异性免疫缺陷中 B 细胞免疫表型的变化:原因还是结果 - 支气管扩张是否表明存在未确诊的免疫缺陷?
Clin Exp Immunol. 2013 Feb;171(2):195-200. doi: 10.1111/cei.12010.
5
Prevalence of airway and parenchymal abnormalities in newly diagnosed rheumatoid arthritis.新诊断类风湿关节炎患者的气道和实质异常的患病率。
Respir Med. 2012 Oct;106(10):1441-6. doi: 10.1016/j.rmed.2012.06.020. Epub 2012 Jul 13.
6
Chronic respiratory disease, inhaled corticosteroids and risk of non-tuberculous mycobacteriosis.慢性呼吸道疾病、吸入性皮质类固醇与非结核分枝杆菌病风险。
Thorax. 2013 Mar;68(3):256-62. doi: 10.1136/thoraxjnl-2012-201772. Epub 2012 Jul 10.
7
Prevalence of nontuberculous mycobacterial lung disease in U.S. Medicare beneficiaries.美国医疗保险受益人群中非结核分枝杆菌肺病的流行率。
Am J Respir Crit Care Med. 2012 Apr 15;185(8):881-6. doi: 10.1164/rccm.201111-2016OC. Epub 2012 Feb 3.
8
Immune defects in active mycobacterial diseases in patients with primary immunodeficiency diseases (PIDs).原发性免疫缺陷病(PIDs)患者活动性分枝杆菌病中的免疫缺陷。
J Formos Med Assoc. 2011 Dec;110(12):750-8. doi: 10.1016/j.jfma.2011.11.004. Epub 2011 Dec 23.
9
Aging, COPD, and other risk factors do not explain the increased prevalence of pulmonary Mycobacterium avium complex in Ontario.在安大略省,衰老、COPD 和其他风险因素并不能解释肺部鸟分枝杆菌复合体患病率的增加。
Chest. 2012 Jan;141(1):190-197. doi: 10.1378/chest.11-0089. Epub 2011 Jun 30.
10
The reliability of diagnostic coding and laboratory data to identify tuberculosis and nontuberculous mycobacterial disease among rheumatoid arthritis patients using anti-tumor necrosis factor therapy.使用抗肿瘤坏死因子治疗的类风湿关节炎患者中,诊断编码和实验室数据对识别结核和非结核分枝杆菌病的可靠性。
Pharmacoepidemiol Drug Saf. 2011 Mar;20(3):229-35. doi: 10.1002/pds.2049. Epub 2010 Dec 10.